New and increasingly more sophisticated technologies impacting the blood bank/transfusion services have been widely deployed, enhancing the blood bank operations in a safe and effective manner. When considering the introduction of new instrumentation or new methodologies, it is incumbent on the manager or other laboratory representative responsible for operations to fully assess the needs of the laboratory, the opportunities that the new technology provides, and the “cost” of validation and implementation both in terms of man power and capital/operational impact.
The goal of this webinar is to educate the audience about the safe and effective blood component delivery to the patient bedside and key components of validation/verification of delivery systems, highlighting the many regulatory requirements promulgated by both federal agencies (FDA, HHS, and CDC) and organizations responsible for laboratory assessment (TJC, AABB, CAP, and state agencies).
Presentation topics include:
- Recognize the impact of safe blood delivery for effective blood transfusion.
- Grow to understand pneumatic tube delivery systems and their contribution to safe and effective blood delivery
- Recognize the key building blocks for successful validation/verification outcomes associated with implementation of blood delivery via pneumatic tube systems
- Appreciate the status of investigation of alternative delivery modes that expand beyond the boundaries of a hospital building.
Click here to register via GoToWebinar.
Thursday, April 4, 2024: 11:00 a.m.- noon. (PT)
Lynne Uhl, MD
Vice Chair for Laboratory and Transfusion Medicine, Beth Israel Deaconess Medical Center
Division Director, Laboratory and Transfusion Medicine, Beth Israel
Deaconess Medical CenterAssociate Professor of Pathology, Harvard Medical School
Lynne Uhl,MD is the Vice Chair, Division of Laboratory and Transfusion Medicine at the Beth Israel Deaconess Medical Center, Boston, MA and an Associate Professor of Pathology at Harvard Medical School. Dr. Uhl received her medical degree from University of Cincinnati College of Medicine, Cincinnati, OH and completed residency training in pathology at Beth Israel Hospital and Harvard Medical School, Boston, MA. Her areas of interest include evidence-based clinical transfusion practice, blood bank operations, and clinical laboratory operations. She is board-certified in anatomic and clinical pathology and has subspecialty certification in blood banking and transfusion medicine.
HQI is an approved continuing education (CE) provider by the California Board of Registered Nursing and will provide CHPSO members an opportunity to earn CEs. Provider Number CEP16793 for 1.0 contact hour.
Please contact CHPSO at info@chpso.org if you have any questions.